- Published on
Ophthalmology – Ehlers–Danlos Syndrome
Ehlers–Danlos syndrome (EDS) is a group of inherited connective tissue disorders characterized by joint hypermobility, hyperextensible skin, and tissue fragility. It encompasses several subtypes, including the classic, hypermobility, vascular, kyphoscoliosis (ocular-scoliotic), arthrochalasis, dermatosparaxis, and tenascin-X–deficient types, each with varying systemic and ocular involvement. The kyphoscoliosis type is particularly important in ophthalmology due to its association with globe fragility and severe ocular complications.
EDS has an estimated prevalence of 1 in 5,000–10,000 individuals, though milder forms may go undiagnosed. The condition arises from genetic mutations affecting collagen synthesis or structure, involving genes such as COL1A2, COL3A1, COL5A1, COL5A2, and others. Depending on the subtype, inheritance may be autosomal dominant or autosomal recessive. These mutations result in defective collagen, particularly types I and III, leading to weakened connective tissues throughout the body.
Clinically, patients often present with soft, hyperextensible, fragile skin, easy bruising, and joint laxity with frequent dislocations. Poor wound healing and abnormal scarring are common. Systemic manifestations may include cardiac abnormalities (such as mitral valve prolapse), gastrointestinal issues, and musculoskeletal deformities like scoliosis or flat feet.
Ocular involvement is diverse and clinically significant. Patients may develop retinal detachment, retinal hemorrhages, keratoconus, lens subluxation (ectopia lentis), glaucoma, strabismus, and severe myopia. Other notable features include blue sclera, angioid streaks, dry eye symptoms, and in severe cases, globe rupture due to scleral fragility. These findings highlight the importance of regular ophthalmologic monitoring in affected individuals.
Diagnosis is primarily clinical, supported by genetic testing and specialized studies such as collagen analysis. Additional evaluations may include echocardiography to assess cardiac involvement. Histologically, collagen fibers appear irregular, sparse, and disorganized. There are no routine screening laboratory tests, but targeted testing is guided by suspected subtype.
Management of EDS is largely supportive, as there is no definitive cure. Patients are advised to avoid trauma and contact sports, particularly in high-risk subtypes such as vascular EDS. Vitamin C supplementation may be recommended as it plays a role in collagen synthesis, though evidence is limited. Surgical procedures require special caution due to poor wound healing and increased bleeding risk.
Ongoing care involves a multidisciplinary approach, including ophthalmology, cardiology, orthopedics, and genetics. Regular eye examinations are essential to monitor for complications such as retinal detachment or glaucoma. Genetic counseling is strongly recommended, especially for family planning.
The prognosis varies by subtype. Many individuals have a normal lifespan, particularly in milder forms, but more severe types—especially the vascular and kyphoscoliosis forms—carry risks of arterial rupture, organ rupture, and ocular complications, which can be life-threatening.
Ehlers–Danlos syndrome (EDS) is a group of inherited connective tissue disorders characterized by joint hypermobility, hyperextensible skin, and tissue fragility. It encompasses several subtypes, including the classic, hypermobility, vascular, kyphoscoliosis (ocular-scoliotic), arthrochalasis, dermatosparaxis, and tenascin-X–deficient types, each with varying systemic and ocular involvement. The kyphoscoliosis type is particularly important in ophthalmology due to its association with globe fragility and severe ocular complications.
EDS has an estimated prevalence of 1 in 5,000–10,000 individuals, though milder forms may go undiagnosed. The condition arises from genetic mutations affecting collagen synthesis or structure, involving genes such as COL1A2, COL3A1, COL5A1, COL5A2, and others. Depending on the subtype, inheritance may be autosomal dominant or autosomal recessive. These mutations result in defective collagen, particularly types I and III, leading to weakened connective tissues throughout the body.
Clinically, patients often present with soft, hyperextensible, fragile skin, easy bruising, and joint laxity with frequent dislocations. Poor wound healing and abnormal scarring are common. Systemic manifestations may include cardiac abnormalities (such as mitral valve prolapse), gastrointestinal issues, and musculoskeletal deformities like scoliosis or flat feet.
Ocular involvement is diverse and clinically significant. Patients may develop retinal detachment, retinal hemorrhages, keratoconus, lens subluxation (ectopia lentis), glaucoma, strabismus, and severe myopia. Other notable features include blue sclera, angioid streaks, dry eye symptoms, and in severe cases, globe rupture due to scleral fragility. These findings highlight the importance of regular ophthalmologic monitoring in affected individuals.
Diagnosis is primarily clinical, supported by genetic testing and specialized studies such as collagen analysis. Additional evaluations may include echocardiography to assess cardiac involvement. Histologically, collagen fibers appear irregular, sparse, and disorganized. There are no routine screening laboratory tests, but targeted testing is guided by suspected subtype.
Management of EDS is largely supportive, as there is no definitive cure. Patients are advised to avoid trauma and contact sports, particularly in high-risk subtypes such as vascular EDS. Vitamin C supplementation may be recommended as it plays a role in collagen synthesis, though evidence is limited. Surgical procedures require special caution due to poor wound healing and increased bleeding risk.
Ongoing care involves a multidisciplinary approach, including ophthalmology, cardiology, orthopedics, and genetics. Regular eye examinations are essential to monitor for complications such as retinal detachment or glaucoma. Genetic counseling is strongly recommended, especially for family planning.
The prognosis varies by subtype. Many individuals have a normal lifespan, particularly in milder forms, but more severe types—especially the vascular and kyphoscoliosis forms—carry risks of arterial rupture, organ rupture, and ocular complications, which can be life-threatening.
- Published on
Ophthalmology – Ectropion
Ectropion is defined as an outward turning (eversion) of the eyelid margin, most commonly affecting the lower eyelid. This malposition disrupts normal eyelid function, leading to exposure of the ocular surface and improper tear drainage. Ectropion is classified into several types, including involutional (age-related, most common), paralytic, cicatricial, and congenital forms.
The condition is most frequently seen in older adults, particularly due to age-related tissue changes. Risk factors include sun exposure, smoking, diabetes, hypertension, and prior facial or eyelid surgery. Paralytic ectropion is often associated with facial nerve (7th nerve) palsy, such as in Bell’s palsy, while cicatricial ectropion results from skin contracture due to scarring, trauma, inflammation, or tumors.
Pathophysiologically, involutional ectropion results from horizontal eyelid laxity and weakening of supporting structures. Paralytic ectropion occurs due to loss of orbicularis oculi muscle tone, leading to poor eyelid closure and sagging. Cicatricial ectropion is caused by shortening or tightening of the anterior lamella (skin), pulling the eyelid outward. These mechanisms ultimately result in poor eyelid-globe apposition and exposure of the conjunctiva and cornea.
Patients typically present with tearing (epiphora), redness, foreign body sensation, mucous discharge, and irritation. Symptoms occur because the lacrimal punctum is everted, preventing proper tear drainage, and because of ocular surface exposure. On examination, findings include visible outward turning of the eyelid, punctal eversion, lagophthalmos (incomplete eyelid closure), conjunctival redness, and superficial punctate keratitis. In paralytic cases, signs of facial nerve dysfunction such as reduced eyelid closure strength are evident.
Diagnosis is primarily clinical, though additional testing may be required depending on the cause. For example, Lyme titers may be checked in suspected infectious facial palsy, and evaluation for herpes zoster or systemic disease may be indicated. The differential diagnosis includes conditions such as thyroid eye disease and floppy eyelid syndrome.
Management depends on severity and underlying cause. Initial treatment focuses on ocular surface protection, including artificial tears, gels, and ointments to prevent dryness and corneal damage. In cases of infection or inflammation, topical antibiotic or steroid ointments may be used. For paralytic ectropion, treatment may include systemic corticosteroids, antivirals, or antibiotics, depending on etiology.
Supportive measures include warm compresses, eyelid taping, and massage, particularly in mild or temporary cases. However, definitive treatment is often surgical. Involutional ectropion is typically corrected with horizontal eyelid tightening procedures, while paralytic ectropion may require procedures such as gold weight implantation in the upper eyelid to improve closure. Cicatricial ectropion often requires skin grafting or reconstructive procedures to address tissue deficiency.
Follow-up is important to monitor for complications, particularly corneal exposure. Prognosis is generally good, especially when treated early. However, untreated ectropion can lead to serious complications such as corneal abrasion, ulceration, scarring, and even perforation, making timely management essential.
Ectropion is defined as an outward turning (eversion) of the eyelid margin, most commonly affecting the lower eyelid. This malposition disrupts normal eyelid function, leading to exposure of the ocular surface and improper tear drainage. Ectropion is classified into several types, including involutional (age-related, most common), paralytic, cicatricial, and congenital forms.
The condition is most frequently seen in older adults, particularly due to age-related tissue changes. Risk factors include sun exposure, smoking, diabetes, hypertension, and prior facial or eyelid surgery. Paralytic ectropion is often associated with facial nerve (7th nerve) palsy, such as in Bell’s palsy, while cicatricial ectropion results from skin contracture due to scarring, trauma, inflammation, or tumors.
Pathophysiologically, involutional ectropion results from horizontal eyelid laxity and weakening of supporting structures. Paralytic ectropion occurs due to loss of orbicularis oculi muscle tone, leading to poor eyelid closure and sagging. Cicatricial ectropion is caused by shortening or tightening of the anterior lamella (skin), pulling the eyelid outward. These mechanisms ultimately result in poor eyelid-globe apposition and exposure of the conjunctiva and cornea.
Patients typically present with tearing (epiphora), redness, foreign body sensation, mucous discharge, and irritation. Symptoms occur because the lacrimal punctum is everted, preventing proper tear drainage, and because of ocular surface exposure. On examination, findings include visible outward turning of the eyelid, punctal eversion, lagophthalmos (incomplete eyelid closure), conjunctival redness, and superficial punctate keratitis. In paralytic cases, signs of facial nerve dysfunction such as reduced eyelid closure strength are evident.
Diagnosis is primarily clinical, though additional testing may be required depending on the cause. For example, Lyme titers may be checked in suspected infectious facial palsy, and evaluation for herpes zoster or systemic disease may be indicated. The differential diagnosis includes conditions such as thyroid eye disease and floppy eyelid syndrome.
Management depends on severity and underlying cause. Initial treatment focuses on ocular surface protection, including artificial tears, gels, and ointments to prevent dryness and corneal damage. In cases of infection or inflammation, topical antibiotic or steroid ointments may be used. For paralytic ectropion, treatment may include systemic corticosteroids, antivirals, or antibiotics, depending on etiology.
Supportive measures include warm compresses, eyelid taping, and massage, particularly in mild or temporary cases. However, definitive treatment is often surgical. Involutional ectropion is typically corrected with horizontal eyelid tightening procedures, while paralytic ectropion may require procedures such as gold weight implantation in the upper eyelid to improve closure. Cicatricial ectropion often requires skin grafting or reconstructive procedures to address tissue deficiency.
Follow-up is important to monitor for complications, particularly corneal exposure. Prognosis is generally good, especially when treated early. However, untreated ectropion can lead to serious complications such as corneal abrasion, ulceration, scarring, and even perforation, making timely management essential.
- Published on
Ophthalmology – Ectopia Lentis
Ectopia lentis refers to displacement of the crystalline lens from its normal position due to weakness or disruption of the zonular fibers. The condition may present as subluxation (partial displacement) or luxation (complete dislocation). It can occur as an isolated ocular finding or as part of systemic connective tissue or metabolic disorders, and may also result from trauma.
The condition is strongly associated with systemic diseases such as Marfan syndrome (where 60–75% of patients develop ectopia lentis) and homocystinuria (seen in 80–85% of cases). Other associations include Ehlers–Danlos syndrome, Weill–Marchesani syndrome, hyperlysinemia, sulfite oxidase deficiency, and congenital ocular anomalies. Trauma is also an important cause, particularly in unilateral cases. Genetically, ectopia lentis may be inherited in autosomal dominant or recessive patterns, often involving mutations in genes such as FBN1 (fibrillin) or ADAMTSL4, both critical for zonular integrity.
The underlying pathophysiology involves weakening, stretching, or rupture of the zonular fibers that suspend the lens. In connective tissue disorders like Marfan syndrome, abnormal fibrillin leads to fragile zonules, whereas in metabolic disorders like homocystinuria, defective cysteine metabolism weakens zonular structure. This results in progressive lens instability and displacement.
Patients may present with blurred vision, monocular diplopia, or fluctuating refractive error, depending on the degree of lens displacement. A history of trauma or systemic disease, or a family history, may be present. On examination, slit-lamp findings reveal decentered lens position, abnormal zonules (stretched, broken, or absent), and sometimes irregular lens edges. Additional findings may include corectopia (displaced pupil), elevated intraocular pressure, or signs of associated systemic disease.
Diagnostic evaluation includes a thorough ocular exam and systemic assessment. In patients without trauma or known diagnosis, serum or urine homocysteine levels should be checked due to the serious systemic risks of homocystinuria, including thromboembolism. Imaging such as echocardiography may be required when conditions like Marfan syndrome are suspected. Genetic testing may help confirm the diagnosis in selected cases.
Management depends on severity and underlying cause. Initial treatment focuses on optical correction with glasses or contact lenses and treatment of amblyopia, especially in children. In cases where the lens dislocates into the anterior chamber, urgent management is required to prevent pupillary block glaucoma, including medications such as mannitol, steroids, and mydriatics, along with positioning the patient supine.
Surgical treatment is indicated when vision cannot be corrected optically or when complications arise. This typically involves lensectomy with anterior vitrectomy, followed by visual rehabilitation using contact lenses or aphakic spectacles. In some cases, intraocular lens implantation may be considered, though this is often limited in children due to poor zonular support.
Regular follow-up is essential to monitor for progressive lens displacement, amblyopia, glaucoma, and retinal detachment, particularly in conditions like Marfan syndrome. Prognosis is generally good with early diagnosis and appropriate management, with many patients achieving visual acuity of 20/40 or better, provided complications are addressed promptly.
Ectopia lentis refers to displacement of the crystalline lens from its normal position due to weakness or disruption of the zonular fibers. The condition may present as subluxation (partial displacement) or luxation (complete dislocation). It can occur as an isolated ocular finding or as part of systemic connective tissue or metabolic disorders, and may also result from trauma.
The condition is strongly associated with systemic diseases such as Marfan syndrome (where 60–75% of patients develop ectopia lentis) and homocystinuria (seen in 80–85% of cases). Other associations include Ehlers–Danlos syndrome, Weill–Marchesani syndrome, hyperlysinemia, sulfite oxidase deficiency, and congenital ocular anomalies. Trauma is also an important cause, particularly in unilateral cases. Genetically, ectopia lentis may be inherited in autosomal dominant or recessive patterns, often involving mutations in genes such as FBN1 (fibrillin) or ADAMTSL4, both critical for zonular integrity.
The underlying pathophysiology involves weakening, stretching, or rupture of the zonular fibers that suspend the lens. In connective tissue disorders like Marfan syndrome, abnormal fibrillin leads to fragile zonules, whereas in metabolic disorders like homocystinuria, defective cysteine metabolism weakens zonular structure. This results in progressive lens instability and displacement.
Patients may present with blurred vision, monocular diplopia, or fluctuating refractive error, depending on the degree of lens displacement. A history of trauma or systemic disease, or a family history, may be present. On examination, slit-lamp findings reveal decentered lens position, abnormal zonules (stretched, broken, or absent), and sometimes irregular lens edges. Additional findings may include corectopia (displaced pupil), elevated intraocular pressure, or signs of associated systemic disease.
Diagnostic evaluation includes a thorough ocular exam and systemic assessment. In patients without trauma or known diagnosis, serum or urine homocysteine levels should be checked due to the serious systemic risks of homocystinuria, including thromboembolism. Imaging such as echocardiography may be required when conditions like Marfan syndrome are suspected. Genetic testing may help confirm the diagnosis in selected cases.
Management depends on severity and underlying cause. Initial treatment focuses on optical correction with glasses or contact lenses and treatment of amblyopia, especially in children. In cases where the lens dislocates into the anterior chamber, urgent management is required to prevent pupillary block glaucoma, including medications such as mannitol, steroids, and mydriatics, along with positioning the patient supine.
Surgical treatment is indicated when vision cannot be corrected optically or when complications arise. This typically involves lensectomy with anterior vitrectomy, followed by visual rehabilitation using contact lenses or aphakic spectacles. In some cases, intraocular lens implantation may be considered, though this is often limited in children due to poor zonular support.
Regular follow-up is essential to monitor for progressive lens displacement, amblyopia, glaucoma, and retinal detachment, particularly in conditions like Marfan syndrome. Prognosis is generally good with early diagnosis and appropriate management, with many patients achieving visual acuity of 20/40 or better, provided complications are addressed promptly.
- Published on
Ophthalmology – Eales Disease
Eales disease is an idiopathic obliterative retinal vasculopathy that primarily affects young adults, classically presenting with a triad of retinal phlebitis, peripheral retinal nonperfusion, and recurrent vitreous hemorrhage. It is considered a diagnosis of exclusion, meaning other causes of retinal vasculitis must be ruled out before confirming the condition.
The disease is most commonly reported in regions such as India and the Middle East, typically affecting individuals between 20 and 30 years of age. Earlier studies suggested a male predominance, but more recent data indicate a more equal gender distribution. A possible association with hypersensitivity to tuberculin protein has been proposed, and tubercle bacilli have occasionally been identified in pathological specimens, although the exact cause remains unclear.
Pathophysiologically, Eales disease involves a nonspecific inflammatory occlusive vasculitis, primarily affecting retinal veins. This leads to vascular inflammation (phlebitis), followed by capillary closure and ischemia, which in turn stimulates retinal neovascularization. These fragile new vessels are prone to bleeding, resulting in recurrent vitreous hemorrhage, a hallmark complication.
Patients commonly present with decreased vision, floaters, or “cobweb-like” visual disturbances, often due to vitreous hemorrhage. On examination, findings include retinal vascular sheathing, hemorrhages, and exudates along affected vessels. More than half of patients have bilateral involvement. Additional findings may include vitreous cells, cystoid macular edema, and neovascularization of the retina or optic disc, which can progress to neovascular glaucoma if untreated.
Diagnosis relies heavily on fluorescein angiography, which helps identify areas of retinal nonperfusion, vascular leakage, and neovascularization. Optical coherence tomography (OCT) may detect associated macular edema or epiretinal membranes. Since Eales disease is a diagnosis of exclusion, investigations are necessary to rule out other causes such as diabetes, sickle cell disease, retinal vein occlusion, inflammatory or infectious vasculitis, and systemic autoimmune conditions.
Management focuses on controlling complications. Panretinal photocoagulation (laser therapy) is essential in cases with retinal ischemia and neovascularization to prevent further hemorrhage and tractional complications. Corticosteroids, either systemic or intravitreal, may help reduce inflammation and vascular leakage. Anti-VEGF agents (such as bevacizumab) are sometimes used to induce regression of neovascularization. In advanced cases with persistent vitreous hemorrhage or tractional retinal detachment, vitrectomy surgery may be required.
Patients require regular follow-up every 3 to 12 months, depending on disease severity, to monitor for progression and complications. Education is important—patients should be aware of symptoms such as sudden floaters or vision loss, which may indicate vitreous hemorrhage.
The prognosis is generally favorable with appropriate management, with many patients maintaining visual acuity of 20/40 or better. However, complications such as recurrent vitreous hemorrhage, retinal detachment, and neovascular glaucoma can significantly impact vision if not treated promptly.
Eales disease is an idiopathic obliterative retinal vasculopathy that primarily affects young adults, classically presenting with a triad of retinal phlebitis, peripheral retinal nonperfusion, and recurrent vitreous hemorrhage. It is considered a diagnosis of exclusion, meaning other causes of retinal vasculitis must be ruled out before confirming the condition.
The disease is most commonly reported in regions such as India and the Middle East, typically affecting individuals between 20 and 30 years of age. Earlier studies suggested a male predominance, but more recent data indicate a more equal gender distribution. A possible association with hypersensitivity to tuberculin protein has been proposed, and tubercle bacilli have occasionally been identified in pathological specimens, although the exact cause remains unclear.
Pathophysiologically, Eales disease involves a nonspecific inflammatory occlusive vasculitis, primarily affecting retinal veins. This leads to vascular inflammation (phlebitis), followed by capillary closure and ischemia, which in turn stimulates retinal neovascularization. These fragile new vessels are prone to bleeding, resulting in recurrent vitreous hemorrhage, a hallmark complication.
Patients commonly present with decreased vision, floaters, or “cobweb-like” visual disturbances, often due to vitreous hemorrhage. On examination, findings include retinal vascular sheathing, hemorrhages, and exudates along affected vessels. More than half of patients have bilateral involvement. Additional findings may include vitreous cells, cystoid macular edema, and neovascularization of the retina or optic disc, which can progress to neovascular glaucoma if untreated.
Diagnosis relies heavily on fluorescein angiography, which helps identify areas of retinal nonperfusion, vascular leakage, and neovascularization. Optical coherence tomography (OCT) may detect associated macular edema or epiretinal membranes. Since Eales disease is a diagnosis of exclusion, investigations are necessary to rule out other causes such as diabetes, sickle cell disease, retinal vein occlusion, inflammatory or infectious vasculitis, and systemic autoimmune conditions.
Management focuses on controlling complications. Panretinal photocoagulation (laser therapy) is essential in cases with retinal ischemia and neovascularization to prevent further hemorrhage and tractional complications. Corticosteroids, either systemic or intravitreal, may help reduce inflammation and vascular leakage. Anti-VEGF agents (such as bevacizumab) are sometimes used to induce regression of neovascularization. In advanced cases with persistent vitreous hemorrhage or tractional retinal detachment, vitrectomy surgery may be required.
Patients require regular follow-up every 3 to 12 months, depending on disease severity, to monitor for progression and complications. Education is important—patients should be aware of symptoms such as sudden floaters or vision loss, which may indicate vitreous hemorrhage.
The prognosis is generally favorable with appropriate management, with many patients maintaining visual acuity of 20/40 or better. However, complications such as recurrent vitreous hemorrhage, retinal detachment, and neovascular glaucoma can significantly impact vision if not treated promptly.
- Published on
Ophthalmology – Dyslexia
Dyslexia is a primary reading disorder characterized by difficulty in acquiring accurate and fluent reading skills due to a language-processing abnormality in the brain. It is not caused by poor vision, low intelligence, lack of motivation, or inadequate teaching. Instead, dyslexia primarily results from a deficit in phonological processing, meaning difficulty in recognizing and manipulating the sounds of language. Historically referred to as “word blindness,” it is now well established that dyslexia is not a visual disorder, although children may appear to skip words or reverse letters due to underlying language-processing challenges.
Dyslexia is relatively common, affecting approximately 5–17% of children, with boys diagnosed more frequently than girls. It exists along a continuum of reading ability in the population, with dyslexia representing the lower end. There is a strong genetic component, with heritability estimated between 54–75%. It often runs in families, and multiple genetic loci have been identified, supporting a polygenic inheritance pattern.
The underlying pathophysiology involves abnormal activation of left hemisphere brain regions responsible for reading, particularly the temporoparietal and occipitotemporal areas. Individuals with dyslexia show reduced activity in these regions and may compensate by using alternative neural pathways, such as frontal brain regions. These differences highlight that dyslexia is a neurobiological disorder of language processing, not an ocular or visual tracking problem.
Clinically, younger children may present with language delay, difficulty learning letters, trouble with rhymes, or mispronouncing words. Older children often demonstrate slow, effortful reading, poor spelling, and a mismatch between their reading ability and overall intelligence. Importantly, children with dyslexia generally have normal eye health and visual function, and any abnormal eye movements observed are a consequence—not a cause—of reading difficulty.
Evaluation of suspected dyslexia includes hearing and vision screening to rule out contributing factors, followed by formal educational and neuropsychological testing. Diagnosis is made using standardized assessments of reading, phonological processing, and comprehension by trained specialists such as psychologists or educators. Imaging studies are not routinely required.
Management is centered on early, structured educational intervention, particularly focusing on phonological awareness and decoding skills. Early intervention (especially between ages 6–8) significantly improves outcomes. Older children benefit from academic accommodations, such as extra time, audiobooks, and assistive technology. It is important to note that vision therapy, eye exercises, and colored lenses have not been proven effective for treating dyslexia.
The prognosis is variable but generally reflects a chronic condition rather than a temporary delay. Without early intervention, reading difficulties often persist into adolescence and adulthood. However, with appropriate support and tailored instruction, many individuals with dyslexia can achieve strong academic and functional outcomes.
Dyslexia is a primary reading disorder characterized by difficulty in acquiring accurate and fluent reading skills due to a language-processing abnormality in the brain. It is not caused by poor vision, low intelligence, lack of motivation, or inadequate teaching. Instead, dyslexia primarily results from a deficit in phonological processing, meaning difficulty in recognizing and manipulating the sounds of language. Historically referred to as “word blindness,” it is now well established that dyslexia is not a visual disorder, although children may appear to skip words or reverse letters due to underlying language-processing challenges.
Dyslexia is relatively common, affecting approximately 5–17% of children, with boys diagnosed more frequently than girls. It exists along a continuum of reading ability in the population, with dyslexia representing the lower end. There is a strong genetic component, with heritability estimated between 54–75%. It often runs in families, and multiple genetic loci have been identified, supporting a polygenic inheritance pattern.
The underlying pathophysiology involves abnormal activation of left hemisphere brain regions responsible for reading, particularly the temporoparietal and occipitotemporal areas. Individuals with dyslexia show reduced activity in these regions and may compensate by using alternative neural pathways, such as frontal brain regions. These differences highlight that dyslexia is a neurobiological disorder of language processing, not an ocular or visual tracking problem.
Clinically, younger children may present with language delay, difficulty learning letters, trouble with rhymes, or mispronouncing words. Older children often demonstrate slow, effortful reading, poor spelling, and a mismatch between their reading ability and overall intelligence. Importantly, children with dyslexia generally have normal eye health and visual function, and any abnormal eye movements observed are a consequence—not a cause—of reading difficulty.
Evaluation of suspected dyslexia includes hearing and vision screening to rule out contributing factors, followed by formal educational and neuropsychological testing. Diagnosis is made using standardized assessments of reading, phonological processing, and comprehension by trained specialists such as psychologists or educators. Imaging studies are not routinely required.
Management is centered on early, structured educational intervention, particularly focusing on phonological awareness and decoding skills. Early intervention (especially between ages 6–8) significantly improves outcomes. Older children benefit from academic accommodations, such as extra time, audiobooks, and assistive technology. It is important to note that vision therapy, eye exercises, and colored lenses have not been proven effective for treating dyslexia.
The prognosis is variable but generally reflects a chronic condition rather than a temporary delay. Without early intervention, reading difficulties often persist into adolescence and adulthood. However, with appropriate support and tailored instruction, many individuals with dyslexia can achieve strong academic and functional outcomes.
- Published on
Ophthalmology – Duane Syndrome
Duane syndrome is a congenital eye movement disorder characterized primarily by limited abduction (outward movement of the eye), along with globe retraction and narrowing of the palpebral fissure on attempted adduction. It is classified into three types: Type I, the most common, shows marked limitation of abduction with relatively preserved adduction; Type II shows limitation of adduction with exotropia; and Type III involves limitation of both abduction and adduction. The condition is part of a group known as congenital cranial dysinnervation disorders, reflecting abnormal nerve supply to the extraocular muscles.
Duane syndrome accounts for about 1% of all strabismus cases and is more common in females, with unilateral involvement being more typical than bilateral. Risk factors include thalidomide exposure during early pregnancy and associations with certain congenital syndromes. Genetically, mutations in genes such as CHN1 and CPAH have been identified, usually with an autosomal dominant inheritance pattern, though many cases are sporadic.
The underlying pathophysiology involves absence or hypoplasia of the sixth cranial nerve (abducens nerve) and abnormal innervation of the lateral rectus muscle by the oculomotor nerve. This leads to co-contraction of medial and lateral rectus muscles, causing globe retraction and narrowing of the eyelid fissure during adduction. The characteristic upshoots and downshoots seen in some patients are thought to result from a mechanical “leash effect” or anomalous muscle innervation.
Clinically, children often present with an eye that does not move outward properly, sometimes associated with esotropia and a compensatory head turn (face turn) to maintain binocular vision. On examination, key findings include limited abduction, variable limitation of adduction, globe retraction on adduction, and vertical upshoots or downshoots. A full ocular exam is essential, particularly to assess for amblyopia, refractive error, and abnormal head posture. Some patients may also have associated ocular findings such as iris abnormalities, cataracts, or coloboma, as well as systemic associations like hearing loss.
Diagnosis is primarily clinical, though high-resolution MRI may demonstrate absence or abnormality of the sixth nerve. Audiologic evaluation is recommended in cases with suspected associated syndromes. The differential diagnosis includes sixth nerve palsy, congenital esotropia, and orbital restrictive conditions.
Management focuses on optimizing vision and alignment. Refractive errors and amblyopia must be treated first with glasses or occlusion therapy. Surgical intervention is considered when there is a significant deviation in primary gaze, abnormal head posture, or cosmetically significant globe retraction or up/down shoots. Surgical approaches typically involve recession of the medial or lateral rectus muscles, and in selected cases, muscle transposition procedures. Importantly, resection of the lateral rectus is generally avoided as it can worsen globe retraction.
The prognosis for vision is excellent if amblyopia is addressed early. While surgery can improve alignment and reduce abnormal head posture, it does not fully restore normal eye movements, particularly abduction. Long-term follow-up is important to monitor for amblyopia, recurrent strabismus, and head posture abnormalities.
Duane syndrome is a congenital eye movement disorder characterized primarily by limited abduction (outward movement of the eye), along with globe retraction and narrowing of the palpebral fissure on attempted adduction. It is classified into three types: Type I, the most common, shows marked limitation of abduction with relatively preserved adduction; Type II shows limitation of adduction with exotropia; and Type III involves limitation of both abduction and adduction. The condition is part of a group known as congenital cranial dysinnervation disorders, reflecting abnormal nerve supply to the extraocular muscles.
Duane syndrome accounts for about 1% of all strabismus cases and is more common in females, with unilateral involvement being more typical than bilateral. Risk factors include thalidomide exposure during early pregnancy and associations with certain congenital syndromes. Genetically, mutations in genes such as CHN1 and CPAH have been identified, usually with an autosomal dominant inheritance pattern, though many cases are sporadic.
The underlying pathophysiology involves absence or hypoplasia of the sixth cranial nerve (abducens nerve) and abnormal innervation of the lateral rectus muscle by the oculomotor nerve. This leads to co-contraction of medial and lateral rectus muscles, causing globe retraction and narrowing of the eyelid fissure during adduction. The characteristic upshoots and downshoots seen in some patients are thought to result from a mechanical “leash effect” or anomalous muscle innervation.
Clinically, children often present with an eye that does not move outward properly, sometimes associated with esotropia and a compensatory head turn (face turn) to maintain binocular vision. On examination, key findings include limited abduction, variable limitation of adduction, globe retraction on adduction, and vertical upshoots or downshoots. A full ocular exam is essential, particularly to assess for amblyopia, refractive error, and abnormal head posture. Some patients may also have associated ocular findings such as iris abnormalities, cataracts, or coloboma, as well as systemic associations like hearing loss.
Diagnosis is primarily clinical, though high-resolution MRI may demonstrate absence or abnormality of the sixth nerve. Audiologic evaluation is recommended in cases with suspected associated syndromes. The differential diagnosis includes sixth nerve palsy, congenital esotropia, and orbital restrictive conditions.
Management focuses on optimizing vision and alignment. Refractive errors and amblyopia must be treated first with glasses or occlusion therapy. Surgical intervention is considered when there is a significant deviation in primary gaze, abnormal head posture, or cosmetically significant globe retraction or up/down shoots. Surgical approaches typically involve recession of the medial or lateral rectus muscles, and in selected cases, muscle transposition procedures. Importantly, resection of the lateral rectus is generally avoided as it can worsen globe retraction.
The prognosis for vision is excellent if amblyopia is addressed early. While surgery can improve alignment and reduce abnormal head posture, it does not fully restore normal eye movements, particularly abduction. Long-term follow-up is important to monitor for amblyopia, recurrent strabismus, and head posture abnormalities.
- Published on
Ophthalmology – Esotropia (Infantile)
Infantile esotropia is a large-angle inward deviation of the eyes that develops within the first 6 months of life in an otherwise healthy infant. It is characterized by a constant deviation typically greater than 35 prism diopters, full ocular motility, and minimal or no significant refractive error. Unlike other forms of esotropia, amblyopia is less common at initial presentation, although it may develop later.
This condition accounts for approximately 8% of all childhood esotropia, with overall esotropia affecting about 2% of children under 6 years. A family history of strabismus is a recognized risk factor.
The underlying pathophysiology is thought to involve abnormal binocular visual development early in life. Studies suggest that disruption of normal sensory input during a critical developmental period leads to persistent ocular misalignment. Early restoration of alignment improves binocular outcomes and reduces later complications.
Infantile esotropia is frequently associated with other ocular motor abnormalities that may develop over time. These include inferior oblique overaction, latent nystagmus, dissociated vertical deviation (DVD), and cross-fixation behavior. Cross-fixation, where the child uses the left eye to look right and vice versa, may simulate an abduction deficit but actually reflects preserved motility.
Parents usually notice eye crossing at birth or within the first few months of life. On examination, there is a large, constant, comitant esotropia with normal ocular structures. Refractive error is typically mild (around +2 diopters, normal for age). Fixation may alternate between eyes; if not, amblyopia should be suspected. Apparent limitation of abduction can often be overcome using cover testing or the Doll’s head maneuver, confirming full extraocular movement.
Neuroimaging is not routinely required, but should be considered if there are abnormal eye movements, atypical features, or significant nystagmus.
The differential diagnosis includes pseudoesotropia, Duane syndrome (Type I), Moebius syndrome, congenital sixth nerve palsy, orbital tumors, and nystagmus blockage syndrome.
Management is primarily surgical, with the goal of achieving early ocular alignment to support binocular vision development. The most common procedure is bilateral medial rectus recession, although larger deviations may require additional muscle surgery. Alignment should ideally be achieved before 24 months of age, and earlier intervention may provide better sensory outcomes.
Before surgery, it is important to treat any amblyopia and correct significant refractive errors to rule out an accommodative component. Although rare, spontaneous resolution can occur, but this is not typically relied upon.
Long-term follow-up is essential. Up to 50% of patients may require additional strabismus surgery by age 10 due to recurrence or development of associated conditions such as inferior oblique overaction or DVD. Patients must also be monitored for amblyopia, refractive errors, and secondary accommodative esotropia.
Parents should be counseled regarding the chronic nature of the condition and the need for ongoing monitoring and possible multiple interventions. If amblyopia persists, protective polycarbonate glasses are recommended.
The prognosis for visual acuity is generally good, with most children achieving normal vision in both eyes. However, stereopsis (depth perception) is often poor unless early alignment is achieved.
Complications include recurrent or consecutive strabismus and amblyopia, both of which may require further treatment.
Infantile esotropia is a large-angle inward deviation of the eyes that develops within the first 6 months of life in an otherwise healthy infant. It is characterized by a constant deviation typically greater than 35 prism diopters, full ocular motility, and minimal or no significant refractive error. Unlike other forms of esotropia, amblyopia is less common at initial presentation, although it may develop later.
This condition accounts for approximately 8% of all childhood esotropia, with overall esotropia affecting about 2% of children under 6 years. A family history of strabismus is a recognized risk factor.
The underlying pathophysiology is thought to involve abnormal binocular visual development early in life. Studies suggest that disruption of normal sensory input during a critical developmental period leads to persistent ocular misalignment. Early restoration of alignment improves binocular outcomes and reduces later complications.
Infantile esotropia is frequently associated with other ocular motor abnormalities that may develop over time. These include inferior oblique overaction, latent nystagmus, dissociated vertical deviation (DVD), and cross-fixation behavior. Cross-fixation, where the child uses the left eye to look right and vice versa, may simulate an abduction deficit but actually reflects preserved motility.
Parents usually notice eye crossing at birth or within the first few months of life. On examination, there is a large, constant, comitant esotropia with normal ocular structures. Refractive error is typically mild (around +2 diopters, normal for age). Fixation may alternate between eyes; if not, amblyopia should be suspected. Apparent limitation of abduction can often be overcome using cover testing or the Doll’s head maneuver, confirming full extraocular movement.
Neuroimaging is not routinely required, but should be considered if there are abnormal eye movements, atypical features, or significant nystagmus.
The differential diagnosis includes pseudoesotropia, Duane syndrome (Type I), Moebius syndrome, congenital sixth nerve palsy, orbital tumors, and nystagmus blockage syndrome.
Management is primarily surgical, with the goal of achieving early ocular alignment to support binocular vision development. The most common procedure is bilateral medial rectus recession, although larger deviations may require additional muscle surgery. Alignment should ideally be achieved before 24 months of age, and earlier intervention may provide better sensory outcomes.
Before surgery, it is important to treat any amblyopia and correct significant refractive errors to rule out an accommodative component. Although rare, spontaneous resolution can occur, but this is not typically relied upon.
Long-term follow-up is essential. Up to 50% of patients may require additional strabismus surgery by age 10 due to recurrence or development of associated conditions such as inferior oblique overaction or DVD. Patients must also be monitored for amblyopia, refractive errors, and secondary accommodative esotropia.
Parents should be counseled regarding the chronic nature of the condition and the need for ongoing monitoring and possible multiple interventions. If amblyopia persists, protective polycarbonate glasses are recommended.
The prognosis for visual acuity is generally good, with most children achieving normal vision in both eyes. However, stereopsis (depth perception) is often poor unless early alignment is achieved.
Complications include recurrent or consecutive strabismus and amblyopia, both of which may require further treatment.
- Published on
Ophthalmology – Contact Lens Complications
Contact lens complications can occur in any wearer and range from mild irritation to severe, vision-threatening infections. These complications are broadly categorized into infectious (bacterial, fungal, Acanthamoeba), allergic (giant papillary conjunctivitis), hypoxic (overwear-related), toxic (solution-related), and structural changes such as corneal warpage. Although most issues are preventable, improper lens hygiene and overwear remain major contributors.
The most serious complication is infectious keratitis, particularly bacterial keratitis, which presents with pain, redness, photophobia, and decreased vision. On examination, there is typically a dense corneal infiltrate with an epithelial defect, surrounding edema, and sometimes hypopyon. Fungal keratitis appears more fluffy with satellite lesions, while Acanthamoeba keratitis—often linked to exposure to contaminated water (e.g., lakes, tap water)—causes severe pain out of proportion to findings and may show radial keratoneuritis or a ring infiltrate (late sign).
Noninfectious complications are also common. Contact lens overwear leads to corneal hypoxia, resulting in punctate keratitis, subepithelial infiltrates, and corneal neovascularization. Toxic keratitis can occur from improper use of multipurpose solutions or unneutralized hydrogen peroxide, presenting as diffuse epithelial damage. Giant papillary conjunctivitis (GPC) is an immune-mediated reaction characterized by large papillae on the upper tarsal conjunctiva, itching, and mucus discharge, often related to lens deposits or material.
Diagnosis relies on a careful history of contact lens use, hygiene practices, and symptom onset, along with slit-lamp examination. In suspected infections, corneal scrapings for culture and staining are essential to identify the causative organism and guide therapy.
Management depends on the underlying cause. Bacterial keratitis is treated urgently with frequent topical antibiotics (e.g., fluoroquinolones or fortified antibiotics). Fungal infections require antifungals such as natamycin, while Acanthamoeba keratitis is treated with agents like PHMB and propamidine. Noninfectious conditions improve with cessation of lens use, lubrication, and sometimes topical steroids or antihistamines (for GPC). Severe or nonresponsive infections may require corneal transplantation.
Prevention is critical and includes avoiding overnight wear, proper cleaning and storage, regular replacement of lenses and cases, and avoiding water exposure while wearing lenses. Daily disposable lenses significantly reduce risk.
The prognosis is generally good for mild complications, but central or severe infections can lead to permanent vision loss, especially if treatment is delayed or inappropriate (e.g., steroid use in active infection).
Contact lens complications can occur in any wearer and range from mild irritation to severe, vision-threatening infections. These complications are broadly categorized into infectious (bacterial, fungal, Acanthamoeba), allergic (giant papillary conjunctivitis), hypoxic (overwear-related), toxic (solution-related), and structural changes such as corneal warpage. Although most issues are preventable, improper lens hygiene and overwear remain major contributors.
The most serious complication is infectious keratitis, particularly bacterial keratitis, which presents with pain, redness, photophobia, and decreased vision. On examination, there is typically a dense corneal infiltrate with an epithelial defect, surrounding edema, and sometimes hypopyon. Fungal keratitis appears more fluffy with satellite lesions, while Acanthamoeba keratitis—often linked to exposure to contaminated water (e.g., lakes, tap water)—causes severe pain out of proportion to findings and may show radial keratoneuritis or a ring infiltrate (late sign).
Noninfectious complications are also common. Contact lens overwear leads to corneal hypoxia, resulting in punctate keratitis, subepithelial infiltrates, and corneal neovascularization. Toxic keratitis can occur from improper use of multipurpose solutions or unneutralized hydrogen peroxide, presenting as diffuse epithelial damage. Giant papillary conjunctivitis (GPC) is an immune-mediated reaction characterized by large papillae on the upper tarsal conjunctiva, itching, and mucus discharge, often related to lens deposits or material.
Diagnosis relies on a careful history of contact lens use, hygiene practices, and symptom onset, along with slit-lamp examination. In suspected infections, corneal scrapings for culture and staining are essential to identify the causative organism and guide therapy.
Management depends on the underlying cause. Bacterial keratitis is treated urgently with frequent topical antibiotics (e.g., fluoroquinolones or fortified antibiotics). Fungal infections require antifungals such as natamycin, while Acanthamoeba keratitis is treated with agents like PHMB and propamidine. Noninfectious conditions improve with cessation of lens use, lubrication, and sometimes topical steroids or antihistamines (for GPC). Severe or nonresponsive infections may require corneal transplantation.
Prevention is critical and includes avoiding overnight wear, proper cleaning and storage, regular replacement of lenses and cases, and avoiding water exposure while wearing lenses. Daily disposable lenses significantly reduce risk.
The prognosis is generally good for mild complications, but central or severe infections can lead to permanent vision loss, especially if treatment is delayed or inappropriate (e.g., steroid use in active infection).
- Published on
Ophthalmology – Contact Lens Complications
Contact lens complications can occur in any wearer and range from mild irritation to severe, vision-threatening infections. These complications are broadly categorized into infectious (bacterial, fungal, Acanthamoeba), allergic (giant papillary conjunctivitis), hypoxic (overwear-related), toxic (solution-related), and structural changes such as corneal warpage. Although most issues are preventable, improper lens hygiene and overwear remain major contributors.
The most serious complication is infectious keratitis, particularly bacterial keratitis, which presents with pain, redness, photophobia, and decreased vision. On examination, there is typically a dense corneal infiltrate with an epithelial defect, surrounding edema, and sometimes hypopyon. Fungal keratitis appears more fluffy with satellite lesions, while Acanthamoeba keratitis—often linked to exposure to contaminated water (e.g., lakes, tap water)—causes severe pain out of proportion to findings and may show radial keratoneuritis or a ring infiltrate (late sign).
Noninfectious complications are also common. Contact lens overwear leads to corneal hypoxia, resulting in punctate keratitis, subepithelial infiltrates, and corneal neovascularization. Toxic keratitis can occur from improper use of multipurpose solutions or unneutralized hydrogen peroxide, presenting as diffuse epithelial damage. Giant papillary conjunctivitis (GPC) is an immune-mediated reaction characterized by large papillae on the upper tarsal conjunctiva, itching, and mucus discharge, often related to lens deposits or material.
Diagnosis relies on a careful history of contact lens use, hygiene practices, and symptom onset, along with slit-lamp examination. In suspected infections, corneal scrapings for culture and staining are essential to identify the causative organism and guide therapy.
Management depends on the underlying cause. Bacterial keratitis is treated urgently with frequent topical antibiotics (e.g., fluoroquinolones or fortified antibiotics). Fungal infections require antifungals such as natamycin, while Acanthamoeba keratitis is treated with agents like PHMB and propamidine. Noninfectious conditions improve with cessation of lens use, lubrication, and sometimes topical steroids or antihistamines (for GPC). Severe or nonresponsive infections may require corneal transplantation.
Prevention is critical and includes avoiding overnight wear, proper cleaning and storage, regular replacement of lenses and cases, and avoiding water exposure while wearing lenses. Daily disposable lenses significantly reduce risk.
The prognosis is generally good for mild complications, but central or severe infections can lead to permanent vision loss, especially if treatment is delayed or inappropriate (e.g., steroid use in active infection).
Contact lens complications can occur in any wearer and range from mild irritation to severe, vision-threatening infections. These complications are broadly categorized into infectious (bacterial, fungal, Acanthamoeba), allergic (giant papillary conjunctivitis), hypoxic (overwear-related), toxic (solution-related), and structural changes such as corneal warpage. Although most issues are preventable, improper lens hygiene and overwear remain major contributors.
The most serious complication is infectious keratitis, particularly bacterial keratitis, which presents with pain, redness, photophobia, and decreased vision. On examination, there is typically a dense corneal infiltrate with an epithelial defect, surrounding edema, and sometimes hypopyon. Fungal keratitis appears more fluffy with satellite lesions, while Acanthamoeba keratitis—often linked to exposure to contaminated water (e.g., lakes, tap water)—causes severe pain out of proportion to findings and may show radial keratoneuritis or a ring infiltrate (late sign).
Noninfectious complications are also common. Contact lens overwear leads to corneal hypoxia, resulting in punctate keratitis, subepithelial infiltrates, and corneal neovascularization. Toxic keratitis can occur from improper use of multipurpose solutions or unneutralized hydrogen peroxide, presenting as diffuse epithelial damage. Giant papillary conjunctivitis (GPC) is an immune-mediated reaction characterized by large papillae on the upper tarsal conjunctiva, itching, and mucus discharge, often related to lens deposits or material.
Diagnosis relies on a careful history of contact lens use, hygiene practices, and symptom onset, along with slit-lamp examination. In suspected infections, corneal scrapings for culture and staining are essential to identify the causative organism and guide therapy.
Management depends on the underlying cause. Bacterial keratitis is treated urgently with frequent topical antibiotics (e.g., fluoroquinolones or fortified antibiotics). Fungal infections require antifungals such as natamycin, while Acanthamoeba keratitis is treated with agents like PHMB and propamidine. Noninfectious conditions improve with cessation of lens use, lubrication, and sometimes topical steroids or antihistamines (for GPC). Severe or nonresponsive infections may require corneal transplantation.
Prevention is critical and includes avoiding overnight wear, proper cleaning and storage, regular replacement of lenses and cases, and avoiding water exposure while wearing lenses. Daily disposable lenses significantly reduce risk.
The prognosis is generally good for mild complications, but central or severe infections can lead to permanent vision loss, especially if treatment is delayed or inappropriate (e.g., steroid use in active infection).
- Published on
Ophthalmology – Acute Viral Conjunctivitis
Acute viral conjunctivitis is a very common inflammation of the conjunctiva, most frequently caused by adenovirus, which accounts for the majority of cases worldwide. It affects individuals of all ages and is highly contagious, often spreading rapidly in households, schools, and crowded environments. Viral conjunctivitis represents 20–70% of all acute conjunctivitis cases, making it the most common overall cause.
Patients typically present with a red eye that begins in one eye and spreads to the other within a few days, accompanied by watery or mucoid discharge, irritation, and tearing. A history of recent upper respiratory infection or contact with an infected person is common. Compared to bacterial conjunctivitis, the discharge is more watery rather than purulent. Many patients also develop preauricular lymphadenopathy, which is a helpful distinguishing feature.
On examination, findings include conjunctival injection, follicular reaction on the palpebral conjunctiva, and sometimes microhemorrhages. In more severe forms such as epidemic keratoconjunctivitis (EKC), patients may develop pseudomembranes and later subepithelial infiltrates in the cornea, which can cause decreased vision and photophobia. These infiltrates typically appear 7–10 days after onset. Other viral forms include pharyngoconjunctival fever (PCF) and acute hemorrhagic conjunctivitis.
Diagnosis is primarily clinical, although rapid point-of-care adenovirus testing is available and can confirm the diagnosis within minutes. More advanced tests such as PCR or viral culture are rarely needed in routine cases. It is important to distinguish viral conjunctivitis from bacterial, allergic, or more serious ocular conditions.
Treatment is mainly supportive, as there are no FDA-approved antiviral agents for adenoviral conjunctivitis. Recommended measures include frequent use of preservative-free artificial tears, cold compresses, and strict hygiene practices such as handwashing and avoiding shared towels. Topical antihistamines may help with itching. In cases caused by herpes simplex virus (HSV), antiviral therapy such as topical ganciclovir or trifluridine is required.
Topical steroids may be used cautiously in severe cases with pseudomembranes or visually significant subepithelial infiltrates, but they should be avoided in mild disease because they can prolong viral shedding and worsen infection.
The prognosis is generally excellent, with most patients recovering spontaneously within 1–2 weeks. However, some patients—especially those with EKC—may develop persistent subepithelial infiltrates or chronic dry eye symptoms, which can last for weeks to months. Patients should be educated about the highly contagious nature of the disease and advised that antibiotics are ineffective unless a secondary bacterial infection is present.
Acute viral conjunctivitis is a very common inflammation of the conjunctiva, most frequently caused by adenovirus, which accounts for the majority of cases worldwide. It affects individuals of all ages and is highly contagious, often spreading rapidly in households, schools, and crowded environments. Viral conjunctivitis represents 20–70% of all acute conjunctivitis cases, making it the most common overall cause.
Patients typically present with a red eye that begins in one eye and spreads to the other within a few days, accompanied by watery or mucoid discharge, irritation, and tearing. A history of recent upper respiratory infection or contact with an infected person is common. Compared to bacterial conjunctivitis, the discharge is more watery rather than purulent. Many patients also develop preauricular lymphadenopathy, which is a helpful distinguishing feature.
On examination, findings include conjunctival injection, follicular reaction on the palpebral conjunctiva, and sometimes microhemorrhages. In more severe forms such as epidemic keratoconjunctivitis (EKC), patients may develop pseudomembranes and later subepithelial infiltrates in the cornea, which can cause decreased vision and photophobia. These infiltrates typically appear 7–10 days after onset. Other viral forms include pharyngoconjunctival fever (PCF) and acute hemorrhagic conjunctivitis.
Diagnosis is primarily clinical, although rapid point-of-care adenovirus testing is available and can confirm the diagnosis within minutes. More advanced tests such as PCR or viral culture are rarely needed in routine cases. It is important to distinguish viral conjunctivitis from bacterial, allergic, or more serious ocular conditions.
Treatment is mainly supportive, as there are no FDA-approved antiviral agents for adenoviral conjunctivitis. Recommended measures include frequent use of preservative-free artificial tears, cold compresses, and strict hygiene practices such as handwashing and avoiding shared towels. Topical antihistamines may help with itching. In cases caused by herpes simplex virus (HSV), antiviral therapy such as topical ganciclovir or trifluridine is required.
Topical steroids may be used cautiously in severe cases with pseudomembranes or visually significant subepithelial infiltrates, but they should be avoided in mild disease because they can prolong viral shedding and worsen infection.
The prognosis is generally excellent, with most patients recovering spontaneously within 1–2 weeks. However, some patients—especially those with EKC—may develop persistent subepithelial infiltrates or chronic dry eye symptoms, which can last for weeks to months. Patients should be educated about the highly contagious nature of the disease and advised that antibiotics are ineffective unless a secondary bacterial infection is present.
